SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Winchester DP, Strom EA. Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. CA Cancer J Clin 1998; 48: 10828.
  • 2
    Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275: 9138.
  • 3
    Fowble B, Hanlon AL, Fein DA, Hoffman JP, Sigurdson ER, Patchefsky A, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys 1997; 38: 94957.
  • 4
    Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, et al. Mammography detected clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am 1996; 2: 15865.
  • 5
    Vicini FA, Lacerna MD, Goldstein NS, Horwitz EM, Dmuchowski CF, White JR, et al. Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy. Int J Radiat Oncol Biol Phys 1997; 39: 62735.
  • 6
    Silverstein MJ, Lagios MD, Martino S, Lewinsky BS, Craig PH, Beron PJ, et al. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 1998; 16: 136773.
  • 7
    American Joint Committee on Cancer. Breast. In: FlemingID, CooperJS, HensonDE, HutterRVP, KennedyBJ MurphyGP, et al, editors. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven, 1998: 15970.
  • 8
    White J, Levine A, Gustafson G, Wimbish K, Ingold J, Pettinga J, et al. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma-in-situ of the breast treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995; 31: 7917.
  • 9
    Page DL, Anderson TJ. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987.
  • 10
    Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 11547.
  • 11
    Azzopardi JG. Underdiagnosis of malignancy. In: BenningtonJL, editor. Problems in breast pathology. London: W.B. Saunders, 1979: 1929.
  • 12
    Fechner RE. Ductal carcinoma involving the lobule of the breast. A source of confusion with lobular carcinoma in situ. Cancer 1971;28: 27481.
  • 13
    Lennington WJ, Jensen RA, Dalton LW, et al. Ductal carcinoma in situ of the breast: heterogeneity of individual lesions. Cancer 1994; 73: 11824.
  • 14
    Recht A, Silver B, Schnitt S, Connolly J, Hellman S, Harris J. Breast relapse following primary radiation therapy for early stage breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 1985;11: 12716.
  • 15
    Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 4579.
  • 16
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 16370.
  • 17
    Cox DR. Regression models and life-tables. J R Stat Soc B 1972; 34: 187220.
  • 18
    Fisher B, Dignam J, Wolmark N, Mamounas E, Constantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel project B-17. J Clin Oncol 1998; 16: 44152.
  • 19
    Fisher E, Constantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: Intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 75: 13109.
  • 20
    Goldstein NS, Lacerna MD, Vicini FA. The significance of cancerization of lobules and atypical ductal hyperplasia adjacent to duct carcinoma in situ of the breast with regards to breast conserving therapy. Am J Clin Pathol 1998; 110: 35767.
  • 21
    Goldstein NS, Kestin LL, Vicini FA. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast conserving therapy. Am J Surg Pathol 1999; 23: 13408.
  • 22
    Schnitt SJ, Harris JR, Smith BL. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet? Cancer 1996;77: 218992.
  • 23
    Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996; 77: 226774.
  • 24
    Fisher ER, Sass R, Fisher B, Wicherham L, Paik SM. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer 1986;57: 197208.
  • 25
    Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985;56: 97990.
  • 26
    Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50: 130914.
  • 27
    Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989; 63: 73141.
  • 28
    Page DL, Lagios MD. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 trial: unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer 1995; 75: 121922.
  • 29
    Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 11547.
  • 30
    Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8: 1138.
  • 31
    Fechner RE. One century of mammary carcinoma in situ, what have we learned? Am J Clin Pathol 1993; 100: 65461.
  • 32
    Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994; 74: 174651.
  • 33
    Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SL, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996; 78: 19218.
  • 34
    Silverstein MJ, Gierson ED, Colburn WJ, Cope LM, Furmanski M, Senofsky GM, et al. Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer 1994;73: 29859.
  • 35
    Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999; 340: 145561.
  • 36
    Solin LJ, Yeh IT, Kurtz J, Fourquet A, Recht A, Kuske R, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with beast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer 1993;71: 253242.
  • 37
    Silverstein MJ, Waisman JR, Gamagami P, Gierson ED, Colburn WJ, Roser RJ, et al. Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice. Cancer 1990;66: 1028.
  • 38
    Fisher ER, Leeming R, Anderson S, Redmond C, Fisher B. Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators. J Surg Oncol 1991;47: 13947.
  • 39
    Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. New Engl J Med 1993; 328: 15816.
  • 40
    Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995; 31A: 14257.
  • 41
    Solin LJ, Kurtz J, Fourquet A, Amalric R, Recht A, Bornstein BA, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996; 14: 75463.
  • 42
    Bornstein BA, Recht A, Connolly JL, Schnitt SJ, Cady B, Kaufman C, et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 1991; 67: 713.
  • 43
    Zafrani B, Fourquet A, Vilcoq JR, Legal M, Calle R. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer 1986; 57: 1299301.
  • 44
    Silverstein MJ, Cohlan BF, Gierson ED, Furmanski M, Gamagami P, Colburn WJ, et al. Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992; 28: 6304.
  • 45
    Stotter AT, McNeese M, Oswald MJ, Ames FC, Romsdahl MM. The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer. Int J Radiat Oncol Biol Phys 1990; 18: 2837.
  • 46
    McCormick B, Rosen PO, Kinne D, Cox L, Yaholom J. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991; 21: 28992.
  • 47
    Cutuli B, Teissier E, Piat JM, Jansen JC, Renaud R, Rodier RF, et al. Radical surgery and conservative treatment of ductal carcinoma in situ of the breast. Eur J Cancer 1992; 28: 64954.
  • 48
    Silverstein MJ, Waisman JR, Gierson ED, Colburn W, Gamagami P, Lewinsky BS. Radiation therapy for intraductal carcinoma. Is it an equal alternative? Arch Surg 1991;126: 4248.
  • 49
    Kurtz JM, Jacquemier J, Torhorst J, Spitalier JM, Amalric R, Hunig R, et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 1989; 63: 16305.
  • 50
    Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. A meta-analysis. Cancer 1999;85: 61628.
  • 51
    Holland P, Gandhi A, Knox WF, Wilson M, Baildam AD, Bundred NJ. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer 1998; 77: 1104.
  • 52
    Kini VR, Vicini FA, Frazier R, Victor SJ, Wimbish K, Martinez AA. Mammographic, pathologic and treatment related factors associated with local recurrence in patients with early stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 1999; 43: 3416.
  • 53
    Fourquet A, Zafrani B, Campana F, Clough KB. Institut Curie experience. In: SilversteinMJ, editor. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins, 1997: 3917.
  • 54
    Hughes KS, Lee AKC, McLellan R, Mackarem G, Camus M, Joshi M, et al. Breast-conserving therapy for patients with ductal carcinoma in situ. Breast Dis 1996; 9: 25568.
  • 55
    Sneige N, McNeese M, Atkinson E, Ames F, Kemp B, Sahin A, et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol 1995; 26: 6429.
  • 56
    Hiramatsu H, Bornstein BA, Recht A, Schnitt SJ, Baum JK, Connolly JL, et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ. Possible importance of family history. Cancer J Sci Am 1995;1: 5561.
  • 57
    Kuske RR, Bean JM, Garcia DM, Perez CA, Adriole D, Philpott G, et al. Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 1993; 26: 3916.